As of June 15, 2025, IQVIA Holdings Inc (IQV) reports a Gross Margin of 34.89%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of IQVIA Holdings Inc's Gross Margin
Over recent years, IQVIA Holdings Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 34.89% |
| 2023-12-31 | 34.96% |
| 2022-12-31 | 34.89% |
| 2021-12-31 | 33.45% |
| 2020-12-31 | 33.97% |
This slight upward trend highlights how IQVIA Holdings Inc manages its operational efficiency and pricing power over time.
Comparing IQVIA Holdings Inc's Gross Margin to Peers
To better understand IQVIA Holdings Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| IQVIA Holdings Inc (IQV) | 34.89% |
| Abcellera Biologics Inc (ABCL) | 7775.20% |
| PerkinElmer Inc (PKI) | 6008.00% |
| Inotiv Inc (BASI) | 3015.93% |
| Replicel Life Sciences Inc (RP.V) | 100.00% |
| Quick-Med Technologies Inc (QMDT) | 97.31% |
Compared to its competitors, IQVIA Holdings Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.